01312 華控康泰
公司資料 - 財務狀況表
華控康泰集團有限公司 股票編號: 01312
KONTAFARMA CHINA HOLDINGS LIMITED 集團網址: http://www.kontafarma.com.hk
非流動資產
2025/06 - 中期
港元($)
與去年末期
比較
2024/12
港元($)
2023/12
港元($)
2022/12
港元($)
2021/12
港元($)
投資物業32,524,000-1.146%32,901,00035,424,00041,911,0004,704,000
物業、廠房、設備及其他219,097,000-4.040%228,321,000240,196,000382,158,000520,681,000
租賃土地205,769,000-20.360%258,375,000334,214,000419,007,000589,242,000
無形資產260,073,000-45.345%475,849,000503,048,000569,159,000636,577,000
聯營公司及共同控制公司權益0--0000
其他非流動資產12,995,000-62.847%34,977,00026,696,00018,706,00026,887,000
730,458,000-29.111%1,030,423,0001,139,578,0001,430,941,0001,778,091,000
存貨88,619,0003.098%85,956,00098,266,000111,736,000112,146,000
 
流動資產
現金及銀行結存78,328,000-2.801%80,585,00077,659,000122,595,000167,962,000
其他流動資產255,635,000-34.531%390,468,000411,832,000455,171,000500,576,000
持作出售資產0--0000
422,582,000-24.134%557,009,000587,757,000689,502,000780,684,000
 
流動負債
其他流動負債415,603,000-6.038%442,312,000383,600,000504,707,000702,565,000
持作出售資產相關負債0--0000
415,603,000-6.038%442,312,000383,600,000504,707,000702,565,000
流動資產淨值6,979,000-93.915%114,697,000204,157,000184,795,00078,119,000
資產總額減流動負債737,437,000-35.602%1,145,120,0001,343,735,0001,615,736,0001,856,210,000
 
非流動負債
116,519,000-36.531%183,584,000281,789,000459,455,000518,426,000
 
資本及儲備
   股本11,177,0000.000%11,177,00011,177,00011,177,00011,177,000
   儲備673,817,000-30.357%967,524,0001,046,112,0001,089,930,0001,180,841,000
   其他0--0000
股東資金684,994,000-30.010%978,701,0001,057,289,0001,101,107,0001,192,018,000
非控股權益(64,076,000)273.294%(17,165,000)4,657,00055,174,000145,766,000
其他0--0000
620,918,000-35.424%961,536,0001,061,946,0001,156,281,0001,337,784,000
 
承擔及或然負債
承擔----5,284,00016,883,00093,075,000118,572,000
或然負債----0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.